You are here

Conrad Housand, MSc

Conrad Housand, MSc

Principal Scientist

Before joining ABM, Conrad led research, development, support and consulting activities at AEgis Technologies related to AEgis' suite of tools for biological modeling, predictive pharmacokinetics and pharmacodynamics, and human health risk assessment. For the last 15 years, Conrad has worked closely with scientists in the fields of toxicology, risk assessment and drug discovery in the development and application of modeling and simulation techniques to their research problems. Conrad has provided consulting services on numerous modeling efforts including development of pharmacokinetic models, statistical models, and physics-based models used in the pharmaceutical industry, and has served as the PI on NIH and USAF grants applying computational techniques to the investigation of human health effects of nanomaterial exposure.

Conrad brings over 20 years of experience in software design and development related to numerical simulation tools and platforms, including both commercial and government-funded tools for applications including computational biology, pharmacokinetics and human health risk assessment.